Nuhey News

We talk about the MARKET

Global Cardiac RF Ablation Generators Market Revenue Estimates and Forecasts (2018-2028)

Cardiac radiofrequency ablation is the delivery of an electrode catheter into a specific part of the cardiac cavity through a vein or an artery, and the release of radiofrequency current leads to coagulation necrosis of the local endocardium and subendocardial myocardium, thereby blocking the abnormal conduction beam and origin of tachyarrhythmia. interventional techniques. The damage range of the radiofrequency current introduced into the cardiac cavity through the catheter is 1-3 mm, which will not cause harm to the body. Radiofrequency ablation has become the most effective method for radical treatment of paroxysmal tachycardia. Cardiac RF Ablation Generators are one of the core devices for cardiac radiofrequency ablation.

Max Output RF Power: 50W Below accounting for % of the Cardiac RF Ablation Generators global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Cardiac RF Ablation Generators include Biosense Webster (Johnson & Johnson MedTech), Medtronic, BIOTRONIK, Abbott, RF Medical, Philips, Livetec, Boston Scientific and AngioDynamics, etc. In terms of revenue, the global 3 largest players have a % market share of Cardiac RF Ablation Generators in 2021.

This report focuses on Cardiac RF Ablation Generators volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Cardiac RF Ablation Generators market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Request for a free sample or purchase this report at:

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Max Output RF Power: 50W Below
  • Max Output RF Power: 50-100W
  • Max Output RF Power: 100W Above

Segment by Application

  • Hospitals
  • Medical Research Institute
  • Others

By Company

  • Biosense Webster (Johnson & Johnson MedTech)
  • Medtronic
  • Abbott
  • RF Medical
  • Philips
  • Livetec
  • Boston Scientific
  • AngioDynamics
  • Toray Industries
  • Lifeline
  • Leading Electorn Technology
  • Jinjiang Electronic Science and Technology
  • Microport EP Medtech
  • Apt Medical Inc.
  • MedSphere International

Production by Region

  • North America
  • Europe
  • China

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)


Contact Details:

Mr. Shirish Gupta

Sales Manager

The Market Reports | Industry and Market Reports at its Best

Call: +1-631-407-1315 / +91-750-729-1479